Clinical trial

EVE TRIAL , ALMA SYSTAM

NCT06646653

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-01-11

PhasePHASE3

Study timeline

Study start (actual)2026-01-11Date precision: day

Registry last updated2026-03-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Postpartum Haemorrhage (PPH)unresolved

PPHunresolved

Postpartum Hemorrhage (Primary)unresolved

Interventions

Alma SystemDEVICE

Sponsors & collaborators

ResQ Medical Ltdlead sponsor

Mapped research locations

BrooklynNew York, United States1 JerusalemIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06646653 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.